New Theory on Airfares and Weight Loss Drugs

There’s a fresh theory making the rounds: airline prices could become more affordable as people start losing weight. Analysts from Jefferies have come up with the idea that the increased use of GLP-1 weight loss medications might actually help reduce fuel consumption, which in turn could lower the costs of airline tickets.

According to their analysis, decreasing the average weight of passengers by 10% could lead to a roughly 2% drop in aircraft weight. This is believed to lower fuel expenses by about 1.5% and boost earnings per share by 4%.

Jefferies commented on this, suggesting, “A leaner society equals lower fuel consumption.” They noted that airlines have historically worked to cut down on aircraft weight, making changes to everything from meal offerings to the raw materials used in their operations.

As more options for weight loss medications emerge, the first GLP-1 tablets are starting to enter the market, making them more accessible than ever.

Gary Leff, a travel expert based in Texas and author of the blog View From the Wing, expanded on this during an interview. He pointed out an obvious truth: heavier planes use more fuel. Less passenger weight means less fuel needed. He quipped, “If everyone went to the bathroom before boarding, we’d all weigh a bit less and save on fuel.”

He went on to explain that if average passenger weight decreases, flying would become cheaper for airlines on the same routes. In competitive markets, this could lead to reduced ticket prices as airlines battle for customers.

However, he added a caveat. In areas where flight options are limited, like major cities, any potential cost reductions might benefit airlines more than passengers, with prices remaining steady.

Dr. Krishna Vyas, a plastic surgeon from New York City, weighed in from a clinical perspective. He expressed skepticism about the current effectiveness of GLP-1 drugs, arguing that their usage is “too limited and too temporary” for any significant impact on average passenger weight on a broader scale.

“Most patients stop taking these meds within a year or two, and regaining weight is pretty common,” he noted. So, it’s probably unrealistic to expect that any small savings in fuel would translate to lower fares.

Moreover, he emphasized that while GLP-1 drugs are a key advancement for individual health, trying to link their benefits to airline economics is a stretch, given the current data.

His conclusion was pretty clear: until we have wider access and consistent results at a population level, any expected drop in airfares linked to these medications remains a theoretical idea rather than something we can count on.

Dr. Peter Balazs, a hormone and weight loss expert, also discussed how these medications might change the in-flight experience. He noted that people using GLP-1 drugs typically crave fewer carbohydrates and prefer proteins and fats instead, hinting that airlines might need to rethink their meal options to cater to this shifting demographic.

However, he cautioned that weight loss drugs can lead to digestive issues, like nausea and indigestion, and stressed the importance of airlines considering these side effects for their passengers. His advice was practical: don’t start treatment just before a flight to avoid complications.